Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function
Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible fo...
Gespeichert in:
Veröffentlicht in: | Circulation research 1988-07, Vol.63 (1), p.126-134 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 134 |
---|---|
container_issue | 1 |
container_start_page | 126 |
container_title | Circulation research |
container_volume | 63 |
creator | Lang, Roberto M Carroll, John D Nakamura, Shigeru Itoh, Haruki Rajfer, Sol I |
description | Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible for the elevation in LV filling pressure observed with dopamine, we administered incremental infusions (2, 4, and 6 μg/kg/min) of dopamine to 18 open-chest, anesthetized dogs in the presence and absence of rauwolscine (selective α2-adrenoceptor antagonist) (n = 7), terazosin (selective α1-antagonist) (n = 6), and domperidone (selective dopamine2 antagonist) (n = 5), while measuring pressures in the LV and left atrium and changes in dimension in the LV short-axis (with ultrasonic piezo crystals). Dobutamine (2, 4, and 6 μg/kg/min) was infused in five additional dogs before and after administration of rauwolscine. The time constant of isovolumic pressure decay, peak lengthening rate (mm/sec), LV end-diastolic pressure, and diastolic pressure-dimension relation were computed. A significant elevation in LV end-diastolic pressure and a parallel increase in LV end-diastolic chamber size was observed with dopamine, while a decline in LV end-diastolic pressure occurred with dobutamine. Yet both dopamine and dobutamine caused a dose-related acceleration of pressure decay and augmentation of peak lengthening rate. Furthermore, heart rate declined during the administration of dopamine but rose with dobutamine. In the presence of either rauwolscine or terazosin, dopamine infusion resulted in a positive chronotropic effect and dose-dependent reductions in LV end-diastolic pressure and end-diastolic chamber dimension; arterial pressure fell only after terazosin administration. The hemodynamic actions of dobutamine, however, were unchanged in the presence of rauwolscine. Moreover, domperidone did not alter the hemodynamic responses to dopamine. The results of the present study suggest that activation of prejunctional α2-adrenoceptors and postjunctional α1- and α2-adrenoceptors play an important role in determining the hemodynamic responses to dopamine. The rise in LV filling pressure produced by dopamine can be attributed to venoconstriction resulting from stimulation of postjunctional α1- and α2-receptors. The decrease in heart rate observed with dopamine may also contribute toward the development of elevated LV filling pressures. (Circulation Research 1988;63:126-134) |
doi_str_mv | 10.1161/01.RES.63.1.126 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78252659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78252659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4742-6bef6b131a24e512a23c6c769e243f005cf56204b997e4877783201b88d008053</originalsourceid><addsrcrecordid>eNqFkUtv1DAQgC0EKtvCmROSD4hbUo-d2M6x6oMiLUJaHkcsxzuhBq-92Ikq_j0uu_TKwRp55psZ6RtCXgFrASScM2g3159aKVpogcsnZAU975quV_CUrBhjQ6OEYM_JaSk_GINO8OGEnAihhVCwIt82KSBNE73YZozJ4X5OuVAbt_Qq7e3OR6Qb_Jf2kX5I2yXY2cfvdI3TTL9inLN3NZfplbdlTsE7erNEN_sUX5Bnkw0FXx7jGflyc_358rZZf3z3_vJi3bhOdbyRI05yBAGWd9gDt1w46ZQckHdiYqx3Uy8568ZhUNhppZQWnMGo9ZYxzXpxRt4e5u5z-rVgmc3OF4ch2IhpKUZp3nPZD_8Fqz0tOX8Azw-gy6mUjJPZZ7-z-bcBZh7UGwamqjdSGDBVfe14fRy9jDvcPvJH17X-5li3xdkwZRudL4-Y0kypv4u7A3afwoy5_AzLPWZzhzbMd6ZelAkGvIFB14b6a-oDLv4Ad5SZzg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15286229</pqid></control><display><type>article</type><title>Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lang, Roberto M ; Carroll, John D ; Nakamura, Shigeru ; Itoh, Haruki ; Rajfer, Sol I</creator><creatorcontrib>Lang, Roberto M ; Carroll, John D ; Nakamura, Shigeru ; Itoh, Haruki ; Rajfer, Sol I</creatorcontrib><description>Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible for the elevation in LV filling pressure observed with dopamine, we administered incremental infusions (2, 4, and 6 μg/kg/min) of dopamine to 18 open-chest, anesthetized dogs in the presence and absence of rauwolscine (selective α2-adrenoceptor antagonist) (n = 7), terazosin (selective α1-antagonist) (n = 6), and domperidone (selective dopamine2 antagonist) (n = 5), while measuring pressures in the LV and left atrium and changes in dimension in the LV short-axis (with ultrasonic piezo crystals). Dobutamine (2, 4, and 6 μg/kg/min) was infused in five additional dogs before and after administration of rauwolscine. The time constant of isovolumic pressure decay, peak lengthening rate (mm/sec), LV end-diastolic pressure, and diastolic pressure-dimension relation were computed. A significant elevation in LV end-diastolic pressure and a parallel increase in LV end-diastolic chamber size was observed with dopamine, while a decline in LV end-diastolic pressure occurred with dobutamine. Yet both dopamine and dobutamine caused a dose-related acceleration of pressure decay and augmentation of peak lengthening rate. Furthermore, heart rate declined during the administration of dopamine but rose with dobutamine. In the presence of either rauwolscine or terazosin, dopamine infusion resulted in a positive chronotropic effect and dose-dependent reductions in LV end-diastolic pressure and end-diastolic chamber dimension; arterial pressure fell only after terazosin administration. The hemodynamic actions of dobutamine, however, were unchanged in the presence of rauwolscine. Moreover, domperidone did not alter the hemodynamic responses to dopamine. The results of the present study suggest that activation of prejunctional α2-adrenoceptors and postjunctional α1- and α2-adrenoceptors play an important role in determining the hemodynamic responses to dopamine. The rise in LV filling pressure produced by dopamine can be attributed to venoconstriction resulting from stimulation of postjunctional α1- and α2-receptors. The decrease in heart rate observed with dopamine may also contribute toward the development of elevated LV filling pressures. (Circulation Research 1988;63:126-134)</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/01.RES.63.1.126</identifier><identifier>PMID: 3383371</identifier><identifier>CODEN: CIRUAL</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Animals ; Biological and medical sciences ; Diastole - drug effects ; Dobutamine - pharmacology ; Dogs ; Domperidone - pharmacology ; dopamine ; Dopamine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Heart ; Hemodynamics - drug effects ; Myocardial Contraction - drug effects ; Prazosin - analogs & derivatives ; Prazosin - pharmacology ; Receptors, Adrenergic - physiology ; Receptors, Dopamine - physiology ; Systole - drug effects ; ventricle ; Ventricular Function ; Vertebrates: cardiovascular system ; Yohimbine - pharmacology</subject><ispartof>Circulation research, 1988-07, Vol.63 (1), p.126-134</ispartof><rights>1988 American Heart Association, Inc.</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4742-6bef6b131a24e512a23c6c769e243f005cf56204b997e4877783201b88d008053</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3687,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7807729$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3383371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lang, Roberto M</creatorcontrib><creatorcontrib>Carroll, John D</creatorcontrib><creatorcontrib>Nakamura, Shigeru</creatorcontrib><creatorcontrib>Itoh, Haruki</creatorcontrib><creatorcontrib>Rajfer, Sol I</creatorcontrib><title>Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible for the elevation in LV filling pressure observed with dopamine, we administered incremental infusions (2, 4, and 6 μg/kg/min) of dopamine to 18 open-chest, anesthetized dogs in the presence and absence of rauwolscine (selective α2-adrenoceptor antagonist) (n = 7), terazosin (selective α1-antagonist) (n = 6), and domperidone (selective dopamine2 antagonist) (n = 5), while measuring pressures in the LV and left atrium and changes in dimension in the LV short-axis (with ultrasonic piezo crystals). Dobutamine (2, 4, and 6 μg/kg/min) was infused in five additional dogs before and after administration of rauwolscine. The time constant of isovolumic pressure decay, peak lengthening rate (mm/sec), LV end-diastolic pressure, and diastolic pressure-dimension relation were computed. A significant elevation in LV end-diastolic pressure and a parallel increase in LV end-diastolic chamber size was observed with dopamine, while a decline in LV end-diastolic pressure occurred with dobutamine. Yet both dopamine and dobutamine caused a dose-related acceleration of pressure decay and augmentation of peak lengthening rate. Furthermore, heart rate declined during the administration of dopamine but rose with dobutamine. In the presence of either rauwolscine or terazosin, dopamine infusion resulted in a positive chronotropic effect and dose-dependent reductions in LV end-diastolic pressure and end-diastolic chamber dimension; arterial pressure fell only after terazosin administration. The hemodynamic actions of dobutamine, however, were unchanged in the presence of rauwolscine. Moreover, domperidone did not alter the hemodynamic responses to dopamine. The results of the present study suggest that activation of prejunctional α2-adrenoceptors and postjunctional α1- and α2-adrenoceptors play an important role in determining the hemodynamic responses to dopamine. The rise in LV filling pressure produced by dopamine can be attributed to venoconstriction resulting from stimulation of postjunctional α1- and α2-receptors. The decrease in heart rate observed with dopamine may also contribute toward the development of elevated LV filling pressures. (Circulation Research 1988;63:126-134)</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Diastole - drug effects</subject><subject>Dobutamine - pharmacology</subject><subject>Dogs</subject><subject>Domperidone - pharmacology</subject><subject>dopamine</subject><subject>Dopamine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Heart</subject><subject>Hemodynamics - drug effects</subject><subject>Myocardial Contraction - drug effects</subject><subject>Prazosin - analogs & derivatives</subject><subject>Prazosin - pharmacology</subject><subject>Receptors, Adrenergic - physiology</subject><subject>Receptors, Dopamine - physiology</subject><subject>Systole - drug effects</subject><subject>ventricle</subject><subject>Ventricular Function</subject><subject>Vertebrates: cardiovascular system</subject><subject>Yohimbine - pharmacology</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1DAQgC0EKtvCmROSD4hbUo-d2M6x6oMiLUJaHkcsxzuhBq-92Ikq_j0uu_TKwRp55psZ6RtCXgFrASScM2g3159aKVpogcsnZAU975quV_CUrBhjQ6OEYM_JaSk_GINO8OGEnAihhVCwIt82KSBNE73YZozJ4X5OuVAbt_Qq7e3OR6Qb_Jf2kX5I2yXY2cfvdI3TTL9inLN3NZfplbdlTsE7erNEN_sUX5Bnkw0FXx7jGflyc_358rZZf3z3_vJi3bhOdbyRI05yBAGWd9gDt1w46ZQckHdiYqx3Uy8568ZhUNhppZQWnMGo9ZYxzXpxRt4e5u5z-rVgmc3OF4ch2IhpKUZp3nPZD_8Fqz0tOX8Azw-gy6mUjJPZZ7-z-bcBZh7UGwamqjdSGDBVfe14fRy9jDvcPvJH17X-5li3xdkwZRudL4-Y0kypv4u7A3afwoy5_AzLPWZzhzbMd6ZelAkGvIFB14b6a-oDLv4Ad5SZzg</recordid><startdate>198807</startdate><enddate>198807</enddate><creator>Lang, Roberto M</creator><creator>Carroll, John D</creator><creator>Nakamura, Shigeru</creator><creator>Itoh, Haruki</creator><creator>Rajfer, Sol I</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>198807</creationdate><title>Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function</title><author>Lang, Roberto M ; Carroll, John D ; Nakamura, Shigeru ; Itoh, Haruki ; Rajfer, Sol I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4742-6bef6b131a24e512a23c6c769e243f005cf56204b997e4877783201b88d008053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Diastole - drug effects</topic><topic>Dobutamine - pharmacology</topic><topic>Dogs</topic><topic>Domperidone - pharmacology</topic><topic>dopamine</topic><topic>Dopamine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Heart</topic><topic>Hemodynamics - drug effects</topic><topic>Myocardial Contraction - drug effects</topic><topic>Prazosin - analogs & derivatives</topic><topic>Prazosin - pharmacology</topic><topic>Receptors, Adrenergic - physiology</topic><topic>Receptors, Dopamine - physiology</topic><topic>Systole - drug effects</topic><topic>ventricle</topic><topic>Ventricular Function</topic><topic>Vertebrates: cardiovascular system</topic><topic>Yohimbine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lang, Roberto M</creatorcontrib><creatorcontrib>Carroll, John D</creatorcontrib><creatorcontrib>Nakamura, Shigeru</creatorcontrib><creatorcontrib>Itoh, Haruki</creatorcontrib><creatorcontrib>Rajfer, Sol I</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lang, Roberto M</au><au>Carroll, John D</au><au>Nakamura, Shigeru</au><au>Itoh, Haruki</au><au>Rajfer, Sol I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>1988-07</date><risdate>1988</risdate><volume>63</volume><issue>1</issue><spage>126</spage><epage>134</epage><pages>126-134</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><coden>CIRUAL</coden><abstract>Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible for the elevation in LV filling pressure observed with dopamine, we administered incremental infusions (2, 4, and 6 μg/kg/min) of dopamine to 18 open-chest, anesthetized dogs in the presence and absence of rauwolscine (selective α2-adrenoceptor antagonist) (n = 7), terazosin (selective α1-antagonist) (n = 6), and domperidone (selective dopamine2 antagonist) (n = 5), while measuring pressures in the LV and left atrium and changes in dimension in the LV short-axis (with ultrasonic piezo crystals). Dobutamine (2, 4, and 6 μg/kg/min) was infused in five additional dogs before and after administration of rauwolscine. The time constant of isovolumic pressure decay, peak lengthening rate (mm/sec), LV end-diastolic pressure, and diastolic pressure-dimension relation were computed. A significant elevation in LV end-diastolic pressure and a parallel increase in LV end-diastolic chamber size was observed with dopamine, while a decline in LV end-diastolic pressure occurred with dobutamine. Yet both dopamine and dobutamine caused a dose-related acceleration of pressure decay and augmentation of peak lengthening rate. Furthermore, heart rate declined during the administration of dopamine but rose with dobutamine. In the presence of either rauwolscine or terazosin, dopamine infusion resulted in a positive chronotropic effect and dose-dependent reductions in LV end-diastolic pressure and end-diastolic chamber dimension; arterial pressure fell only after terazosin administration. The hemodynamic actions of dobutamine, however, were unchanged in the presence of rauwolscine. Moreover, domperidone did not alter the hemodynamic responses to dopamine. The results of the present study suggest that activation of prejunctional α2-adrenoceptors and postjunctional α1- and α2-adrenoceptors play an important role in determining the hemodynamic responses to dopamine. The rise in LV filling pressure produced by dopamine can be attributed to venoconstriction resulting from stimulation of postjunctional α1- and α2-receptors. The decrease in heart rate observed with dopamine may also contribute toward the development of elevated LV filling pressures. (Circulation Research 1988;63:126-134)</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>3383371</pmid><doi>10.1161/01.RES.63.1.126</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7330 |
ispartof | Circulation research, 1988-07, Vol.63 (1), p.126-134 |
issn | 0009-7330 1524-4571 |
language | eng |
recordid | cdi_proquest_miscellaneous_78252659 |
source | MEDLINE; American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Animals Biological and medical sciences Diastole - drug effects Dobutamine - pharmacology Dogs Domperidone - pharmacology dopamine Dopamine - pharmacology Fundamental and applied biological sciences. Psychology Heart Hemodynamics - drug effects Myocardial Contraction - drug effects Prazosin - analogs & derivatives Prazosin - pharmacology Receptors, Adrenergic - physiology Receptors, Dopamine - physiology Systole - drug effects ventricle Ventricular Function Vertebrates: cardiovascular system Yohimbine - pharmacology |
title | Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A09%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Adrenoceptors%20and%20Dopamine%20Receptors%20in%20Modulating%20Left%20Ventricular%20Diastolic%20Function&rft.jtitle=Circulation%20research&rft.au=Lang,%20Roberto%20M&rft.date=1988-07&rft.volume=63&rft.issue=1&rft.spage=126&rft.epage=134&rft.pages=126-134&rft.issn=0009-7330&rft.eissn=1524-4571&rft.coden=CIRUAL&rft_id=info:doi/10.1161/01.RES.63.1.126&rft_dat=%3Cproquest_cross%3E78252659%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15286229&rft_id=info:pmid/3383371&rfr_iscdi=true |